Does USTEKINUMAB Cause Device defective? 1,071 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,071 reports of Device defective have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.3% of all adverse event reports for USTEKINUMAB.
1,071
Reports of Device defective with USTEKINUMAB
1.3%
of all USTEKINUMAB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Device defective From USTEKINUMAB?
Of the 1,071 reports, 9 (0.8%) required hospitalization.
Is Device defective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,071 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Device defective?
SOMATROPIN (1,719)
SECUKINUMAB (666)
GUSELKUMAB (574)
GOLIMUMAB (539)
ABATACEPT (458)
ALBUTEROL (445)
TOCILIZUMAB (400)
INSULIN GLARGINE (397)
EXENATIDE (387)
BUDESONIDE\FORMOTEROL (378)
Which USTEKINUMAB Alternatives Have Lower Device defective Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE